Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Laryngol Otol ; : 1-7, 2020 Jan 22.
Artigo em Inglês | MEDLINE | ID: mdl-31964446

RESUMO

OBJECTIVE: The aim of the present study was to evaluate the surgical and functional results of endoscopic butterfly-inlay cartilage myringoplasty and endoscopic push-through myringoplasty in the treatment of anterior perforation of the tympanic membrane. METHOD: This open-label randomised clinical study was conducted on 71 patients with small- and medium-sized anterior perforations of the tympanic membrane. Graft success rate, hearing results, operative time and complications were analysed. RESULTS: Graft success rates for endoscopic butterfly-inlay cartilage myringoplasty and endoscopic push-through myringoplasty were 94.1 and 91.8 per cent, respectively (p > 0.05). Post-operative air-bone gap values significantly improved in both the endoscopic butterfly-inlay cartilage myringoplasty and endoscopic push-through myringoplasty groups. The average operative time was significantly shorter in the endoscopic butterfly-inlay cartilage myringoplasty group (31.5 minutes) compared to the endoscopic push-through myringoplasty group (41.7 minutes; p < 0.05). CONCLUSION: When compared with the endoscopic push-through myringoplasty, the endoscopic butterfly-inlay cartilage myringoplasty technique, which is technically easier to perform, does not require packing and has a shorter operating time. It is a reasonable approach for repair of anterior perforations of the tympanic membrane.

2.
J Laryngol Otol ; 133(12): 1107-1109, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31558169

RESUMO

OBJECTIVE: This case report presents a middle-ear osteoma mimicking otosclerosis that was located at the promontory. The osteoma was successfully excised using an endoscopic transcanal approach without any complication. CASE REPORT: A 21-year-old man presented with a 4-year history of progressive conductive hearing loss (47 dB with a 30-dB air-bone gap) with intermittent tinnitus of recent onset in his right ear. Endoscopic transcanal middle-ear exploration showed that an osteoma located on the promontory was restricting the mobility of the stapes by affecting the anterior crus of the stapes. After transcanal resection of the osteoma, pure tone audiometry improved to 23 dB with a 5-dB air-bone gap. Tinnitus resolved spontaneously without any additional treatment. CONCLUSION: Promontory osteomas, a rare and usually asymptomatic clinical entity, should be taken into consideration in the differential diagnosis in patients with progressive conductive hearing loss and tinnitus with intact stapedial reflexes and normal otoscopic findings.


Assuntos
Neoplasias Ósseas/diagnóstico , Osteoma/diagnóstico , Otosclerose/diagnóstico , Diagnóstico Diferencial , Perda Auditiva Condutiva/etiologia , Humanos , Masculino , Zumbido/etiologia , Adulto Jovem
3.
Genet Couns ; 27(3): 285-293, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-30204958

RESUMO

The aim of the study was to compare the effects of three eNOS gene polymorphisms associated with congenital heart defects, between Down syndrome patients with and without cardiac anomalies. Transthoracic echocardiographic examinations and eNOS single-nucleotide polymorphisms were investigated on seventy-five patients, prospectively. The frequencies of mutant alleles in the eNOS promoter (the -786T/C polymorphism) and exon 7 mutant alleles (the 894G--->T polymorphism) were significantly higher in Down syndrome patients with and without cardiac anomalies. The frequency of the intron GIOT polymorphism did not significantly differ between patients with and without cardiac anomalies. We found a significant relationship between eNOS gene polymorphisms and the congenital heart defects in patients with Down syndrome. Screening for the presence or absence of eNOS polymorphisms may be useful to obtain preliminary data on the risk of congenital heart defects in patients with Down syndrome.


Assuntos
Síndrome de Down/genética , Cardiopatias Congênitas/genética , Óxido Nítrico Sintase Tipo III/genética , Polimorfismo Genético/genética , Adulto , Alelos , Análise Mutacional de DNA , Síndrome de Down/diagnóstico , Éxons/genética , Feminino , Frequência do Gene/genética , Testes Genéticos , Cardiopatias Congênitas/diagnóstico , Humanos , Íntrons/genética , Masculino , Fenótipo , Regiões Promotoras Genéticas/genética , Fatores Sexuais
4.
J Neurosurg Sci ; 54(1): 29-37, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20436396

RESUMO

AIM: The therapeutic effect of sildenafil citrate on cerebral vasospasm after experimental subarachnoid hemorrhage (SAH) was studied in a rat model. METHODS: We used four groups of seven rats were as follows: no SAH, no treatment; SAH only; SAH plus 2 days of peroral sildenafil citrate 5mg/kg treatment and SAH plus 2 days of peroral sildenafil citrate 15 mg/kg treatment. Three different parameters were evaluated including the diameter of the basilar artery, the level of lipid peroxidation and the degree of the apoptosis 48 hours following SAH. RESULTS: The results showed that sildenafil citrate attenuated SAH-induced cerebral vasospasm in the treatment groups in terms of the diameter of the basilar artery and lipid peroxidation in the two treatment groups, but there was no difference in terms of the level of apoptosis. CONCLUSION: This study indicates that further research on the therapeutic effect of sildenafil citrate can be combined with the use of any apoptosis-blocking agent for the treatment of cerebral vasospasm following experimental subarachnoid hemorrhage.


Assuntos
Piperazinas/farmacologia , Hemorragia Subaracnóidea/complicações , Sulfonas/farmacologia , Vasodilatadores/farmacologia , Vasoespasmo Intracraniano/tratamento farmacológico , Animais , Apoptose/efeitos dos fármacos , Modelos Animais de Doenças , Imuno-Histoquímica , Marcação In Situ das Extremidades Cortadas , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Purinas/farmacologia , Ratos , Ratos Sprague-Dawley , Citrato de Sildenafila , Hemorragia Subaracnóidea/patologia , Vasoespasmo Intracraniano/etiologia , Vasoespasmo Intracraniano/patologia , Insuficiência Vertebrobasilar/tratamento farmacológico , Insuficiência Vertebrobasilar/etiologia , Insuficiência Vertebrobasilar/patologia
5.
J Neurosurg Sci ; 54(3): 125-7, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21423081

RESUMO

Guyon's canal syndrome is an ulnar nerve entrapment at the wrist or palm that can cause motor, sensory or combined motor and sensory loss due to various factors . In this report, we presented a 66-year-old man admitted to our clinic with a history of intermittent pain in the left palm and numbness in 4th and 5th finger for two years. His neurological examination revealed a sensory impairment in the right fifth finger. Also, physical examination displayed a subcutaneous mobile soft tissue in ulnar side of the wrist. Electromyographic examination confirmed the diagnosis of type-1 Guyon's canal syndrome. Under axillary blockage, a lipoma compressing the ulnar nerve was excised totally and ulnar nerve was decompressed. The symptoms were improved after the surgery and patient was symptom free on 3rd postoperative week.


Assuntos
Lipoma/complicações , Neoplasias de Tecidos Moles/complicações , Síndromes de Compressão do Nervo Ulnar/etiologia , Idoso , Eletromiografia , Humanos , Lipoma/cirurgia , Masculino , Neoplasias de Tecidos Moles/cirurgia , Resultado do Tratamento , Síndromes de Compressão do Nervo Ulnar/diagnóstico
7.
Spinal Cord ; 45(12): 780-6, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17724451

RESUMO

STUDY DESIGN: A rat model of spinal cord injury was used to test the hypothesis that Nogo-A monoclonal antibody (NEP1-40) promotes morphologic and functional recoveries of injured spinal cord. OBJECTIVE: Nogo-A is a myelin-associated neurite outgrowth inhibitory protein, which blocks elongation nerve fibers and limits neuronal regeneration after central nervous system injury. METHODS: Forty-four rats were utilized and allocated into control (vehicle) and NEP1-40-treated groups. In all animals, the spinal cord was hemi-transected at Th-10 and phosphate-buffered saline solution was immediately applied on the injured area in the control group. NEP1-40 solution was immediately applied on the hemi-transected area in the treatment group. Each group was subdivided into three subgroups according to the postsurgical day of killing (3, 8 and 21 days). The spinal cords were removed for analysis. RESULTS: Motor scores in the NEP1-40-treated groups were significantly higher than those in the vehicle groups both at 8 and 21 days post injury. Immunohistochemical staining for pan-cadherin, a marker of neuronal cell adhesion and axonal sprouting, revealed a significant increase in staining in the NEP1-40 treatment group at 8 and 21 days post injury. Transmission electron microscopical evaluation revealed degeneration of the myelin and loss of cytoarchitectural organization in the axons of controls. Better preservation and normal histologic features were observed in the NEP1-40-treated groups. CONCLUSION: We have demonstrated improved preservation of injured axons and significant pan-cadherin expression after NEP1-40 treatment after the spinal cord injury. Inhibition of Nogo-A may improve the capacity for neuronal regeneration after spinal cord injury.


Assuntos
Anticorpos Bloqueadores/farmacologia , Caderinas/biossíntese , Proteínas da Mielina/antagonistas & inibidores , Proteínas da Mielina/farmacologia , Fragmentos de Peptídeos/farmacologia , Traumatismos da Medula Espinal/tratamento farmacológico , Animais , Axônios/fisiologia , Pressão Sanguínea/fisiologia , Dióxido de Carbono/sangue , Concentração de Íons de Hidrogênio , Imuno-Histoquímica , Masculino , Microscopia Eletrônica de Transmissão , Movimento/fisiologia , Bainha de Mielina/patologia , Bainha de Mielina/ultraestrutura , Proteínas Nogo , Oxigênio/sangue , Ratos , Ratos Sprague-Dawley , Traumatismos da Medula Espinal/fisiopatologia , Estimulação Química
8.
Acta Neurochir (Wien) ; 145(8): 715-7; discussion 717, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-14520555

RESUMO

We report a case of 57 year-old man with documented posttraumatic acute subdural hematoma and a linear temporal bone fracture. He suffered from a blunt head injury and presented with sudden loss of consciousness. Within 2 hours he became alert and oriented. Follow-up CT scan of brain 2 hours after the initial one showed resolution and redistribution of the subdural hematoma. To our knowledge, this is the first case in the literature about spontaneous resolution of an acute subdural hematoma in a patient with a linear fracture and the fastest resolution period. In this article, the authors discuss the underlying pathophysiology of this uncommon phenomenon.


Assuntos
Hematoma Subdural Agudo/etiologia , Hematoma Subdural Agudo/fisiopatologia , Fraturas Cranianas/complicações , Osso Temporal/lesões , Humanos , Masculino , Pessoa de Meia-Idade , Remissão Espontânea , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...